Ambulero
BiotechnologyMiami, FL
Total funding$5.5M#22 of 32 in Biotechnology
Founded2019
SectorBiotechnology
HQMiami
About
Ambulero, Inc is a cell and gene therapy spin-out of the University of Miami focused on advancing new therapies to fight vascular disease.
Ambulero is one of 16 Biotechnology companies we track in South Florida — 2% of the region's 662 startups.
Similar companies
View allASP IsotopesBiotechnology | Est. 2021 | MIA | $372M |
SyncromuneBiotechnology | Est. 2020 | MIA | $155M |
Pasithea TherapeuticsBiotechnology | Est. 2020 | MIA | $104M |
Myosin TherapeuticsBiotechnology | Est. 2020 | MIA | $15M |
WeoBiotechnology | Est. 2017 | MIA | $10M |
Details
- Region
- South Florida / Miami
- City
- Miami
- Founded
- 2019
- Sector
- Biotechnology
- Founders
- Omaida Velazquez, Randy Berholtz, Robert Buchanan, Zhao-Jun Liu
- Website
- ambulero.com
South Florida / Miami
South Florida anchors the state's fintech, crypto, and Latin America-facing economy, with a deep bilingual talent pool across Miami, Fort Lauderdale, and Palm Beach.
662companies
$21.0Braised